Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
eli lilly
life sciences
national blog main
alprazolam
amgen
biontech
biotech
boehringer ingelheim
boston
boston top stories
cgrp inhibitors
chronic migraine
clinical trials
colucid pharmaceuticals
curevac
deals
drug enforcement administration
fda
indiana
indiana blog main
indiana top stories
infectious diseases
john shiver
lasmiditan
migraine research foundation
moderna therapeutics
mrna
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
sanofi
teva pharmaceutical
translate bio
triptans
vaccines
What
new
pharmaceutical
2
×
second
2
×
acute
addresses
approval
bets
bio
cancer
causes
comes
companies
condition
cut
date
deal
decades
drug
effective
eli
enticed
evidence
fda
friday
giant
giving
hasn’t
lasmiditan
latest
lilly
lilly’s
medication
medicines
messenger
migraine
molecules
mrna
multiple
oks
primarily
Language
unset
Current search:
pharmaceutical
×
second
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines